|
Volumn 85, Issue 8, 2010, Pages 634-635
|
Effect of oral itraconazole on the pharmacokinetics of tacrolimus in a hematopoietic stem cell transplant recipient with CYP3A5*3/*3
a a b a b a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BLEOMYCIN;
CYTOCHROME P450 3A5;
DACARBAZINE;
DOXORUBICIN;
FLUDARABINE;
ITRACONAZOLE;
MELPHALAN;
METHOTREXATE;
TACROLIMUS;
VINBLASTINE;
ABVD PROTOCOL;
ANTIFUNGAL AGENT;
ANTINEOPLASTIC AGENT;
CYP3A5 PROTEIN, HUMAN;
CYTOCHROME P450 3A;
IMMUNOSUPPRESSIVE AGENT;
ADULT;
CANCER COMBINATION CHEMOTHERAPY;
CASE REPORT;
CONTINUOUS INFUSION;
DRUG DOSE REDUCTION;
DRUG EFFECT;
DRUG METABOLISM;
DRUG SAFETY;
FEMALE;
GRAFT VERSUS HOST REACTION;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HODGKIN DISEASE;
HUMAN;
LETTER;
PRIORITY JOURNAL;
SINGLE NUCLEOTIDE POLYMORPHISM;
ALLELE;
ALLOTRANSPLANTATION;
BONE MARROW TRANSPLANTATION;
DRUG ANTAGONISM;
DRUG COMBINATION;
DRUG INTERACTION;
ENZYMOLOGY;
GENETICS;
GENOTYPE;
HALF LIFE TIME;
INTESTINE;
INTRAVENOUS DRUG ADMINISTRATION;
METABOLISM;
MICROCAPSULE;
MULTIMODALITY CANCER THERAPY;
ORAL DRUG ADMINISTRATION;
ADMINISTRATION, ORAL;
ALLELES;
ANTIFUNGAL AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BLEOMYCIN;
BONE MARROW TRANSPLANTATION;
CAPSULES;
COMBINED MODALITY THERAPY;
CYTOCHROME P-450 CYP3A;
DACARBAZINE;
DOXORUBICIN;
DRUG INTERACTIONS;
DRUG THERAPY, COMBINATION;
FEMALE;
GENOTYPE;
GRAFT VS HOST DISEASE;
HALF-LIFE;
HODGKIN DISEASE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INFUSIONS, INTRAVENOUS;
INTESTINES;
ITRACONAZOLE;
METHOTREXATE;
TACROLIMUS;
TRANSPLANTATION, HOMOLOGOUS;
VINBLASTINE;
YOUNG ADULT;
|
EID: 77955488760
PISSN: 03618609
EISSN: 10968652
Source Type: Journal
DOI: 10.1002/ajh.21759 Document Type: Letter |
Times cited : (9)
|
References (3)
|